OSE Immunotherapeutics
OSE.PA
5,06 €
Share price
4.62%
Change (1 day)
-16.40%
Change (1 year)
Categories
Earnings for OSE Immunotherapeutics (OSE.PA)
Earnings in 2024: €39.83 Million
According to OSE Immunotherapeutics's latest financial reports the company's current earnings are €72.71 Million. In 2024 the company made an earning of €39.83 Million, an increase over its 2023 earnings that were of -€23.23 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for OSE Immunotherapeutics from 2012 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2024 | €39.83 M | -271.53% |
| 2023 | -€23.23 Million | 28.85% |
| 2022 | -€18.03 Million | 4.7% |
| 2021 | -€17.22 Million | -10.56% |
| 2020 | -€19.25 Million | 1214.62% |
| 2019 | -€1.47 Million | -131.1% |
| 2018 | €4.7 M | -136.94% |
| 2017 | -€12.75 Million | -172.42% |
| 2016 | €17.59 M | -415.66% |
| 2015 | -€5.58 Million | 96.72% |
| 2014 | -€2.84 Million | 1033.2% |
| 2013 | -€0.25 Million | -82.59% |
| 2012 | -€1.44 Million |